Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.

Biomed Research International is a prominent open access journal published by HINDAWI LTD, dedicated to advancing the field of biomedical research. With its ISSN 2314-6133 and E-ISSN 2314-6141, this journal has been a significant contributor to the scientific community since its inception in 2013, making scholarly work accessible to a global audience. The journal's scope encompasses a range of disciplines, including biochemistry, genetics, molecular biology, immunology, microbiology, and medicine, reflecting its commitment to interdisciplinary research. Ranked in the Q2 quartile as of 2023 across several relevant categories, Biomed Research International is recognized for its high-quality publications that foster innovation and collaboration in biomedical studies. Researchers, professionals, and students looking to share and gain insights into cutting-edge biomedical discoveries will find this journal an essential resource. With a focus on rapid dissemination of research findings, the journal serves as a vital platform for academics to engage with contemporary issues in health and disease, ultimately contributing to the advancement of medical science.

ACTA VETERINARIA HUNGARICA is a prestigious academic journal published by AKADEMIAI KIADO ZRT, dedicated to the diverse field of veterinary science. With a history spanning over three decades since its inception in 1983, this journal provides a platform for the dissemination of high-quality research, clinical studies, and reviews that contribute to advancing knowledge in veterinary medicine and animal health. Based in Hungary, it has built a respectable reputation, reflected in its Scopus ranking, where it occupies the 84th position out of 194 in the General Veterinary category, placing it within the 56th percentile. Although the journal is not open access, it continues to attract a global audience of researchers, professionals, and students who are keen on exploring advancements in veterinary science as it converges towards its upcoming year of 2024. Readers will find valuable insights that foster innovation and improve animal care practices across various settings, making ACTA VETERINARIA HUNGARICA an essential resource for anyone involved in the veterinary field.

Indonesian Biomedical Journal, published by PRODIA EDUCATION & RESEARCH INST, serves as a vital platform for the dissemination of groundbreaking research in the fields of biochemistry, genetics, and molecular biology, as well as general medicine. Since its inception, this Open Access journal has made significant strides in enhancing accessibility to scientific knowledge, allowing researchers, professionals, and students to engage with high-quality studies without financial barriers. With an ISSN of 2355-9179 and a focus on emerging biomedical topics, the journal has established itself in the academic community, securing Q3 and Q4 rankings in its respective categories for 2023. The journal's commitment to maintaining a rigorous peer-review process ensures that only the most innovative and impactful research is published, fostering an environment that encourages collaborative learning and discovery. As it converges from 2017 to 2024, the Indonesian Biomedical Journal continues to be an essential resource for those involved in advancing biomedical sciences, particularly within the unique context of Indonesia and beyond.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, published by Elsevier Science Inc, is a leading journal in the fields of Infectious Diseases, Microbiology, and Medicine. Since its inception in 1983, this esteemed journal has consistently provided a platform for original research and comprehensive reviews that advance the understanding of diagnostic microbiology and its implications for infectious diseases. With an impressive impact factor placing it in the Q2 category in multiple relevant fields as of 2023, it stands out with Scopus rankings reinforcing its significance in academia, ranking #136 out of 344 in Infectious Diseases and #64 out of 140 in Medical Microbiology. This journal is essential for researchers, healthcare professionals, and students who seek to stay abreast of the latest developments and trends in infectious diagnostics. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE is committed to fostering excellence in research quality and academic rigor, ensuring accessibility to vital knowledge for addressing some of the most pressing health challenges of our time.

Emerging Infectious Diseases, published by the Centers for Disease Control and Prevention, is a leading open-access journal that has been dedicated to the field of epidemiology, infectious diseases, and medical microbiology since its inception in 1995. With an impressive impact factor placing it in the Q1 quartile rankings for multiple categories including Epidemiology, Infectious Diseases, and Medical Microbiology, this journal serves as a vital resource for researchers, practitioners, and students dedicated to combating the challenges posed by emerging infectious diseases. The journal's distinguished Scopus ranks further highlight its global influence, ranking #10 in Epidemiology, #26 in Infectious Diseases, and #13 in Medical Microbiology, all within the top percentiles. Accessible and targeted, Emerging Infectious Diseases publishes seminal research and reviews that contribute to the understanding and management of infectious diseases, ensuring that critical insights reach a broad audience. The journal encourages contributions that advance the scientific community’s knowledge and responses to public health challenges.

JOURNAL OF BIOMEDICAL SCIENCE, published by BMC, is a premier Open Access journal dedicated to the rapid dissemination of research in the fields of biomedical science, encompassing crucial areas such as biochemistry, cell biology, clinical biochemistry, and more. Since its inception in 1993, the journal has established itself as a leading publication, currently boasting a remarkable impact factor and quality as evidenced by its Q1 quartile rankings across multiple categories in 2023. With an impressive track record, including a Scopus ranking in the top percentiles across several disciplines, it serves as a vital resource for researchers, professionals, and students who are keen on advancing their knowledge in biomedicine. The journal operates under a fully Open Access model, ensuring that all published articles are freely available to the global research community, thus contributing to the broader dissemination and accessibility of scientific knowledge. Based in the United Kingdom, JOURNAL OF BIOMEDICAL SCIENCE is committed to fostering innovation and collaboration in research, appealing to those aiming to make impactful contributions to the biomedical sphere.

Asian Biomedicine, published by WALTER DE GRUYTER GMBH, serves as a crucial platform for disseminating pioneering research in the field of biomedical sciences. Established in 2008, this journal has carved its niche in the landscape of academic publishing, concentrating on a diverse array of topics within biochemistry, genetics, and molecular biology, as well as medicine. Though it currently holds a Q4 ranking in its category, it is dedicated to fostering academic discussions and advancing knowledge among researchers, professionals, and students alike. While the journal features a variety of access options, it is committed to ensuring that its content remains relevant and impactful, with an emphasis on the latest developments and research trends. The editorial board encourages submissions that address pressing biomedical issues, thus empowering contributors to engage meaningfully with the scientific community. With a broad international scope and a focus on quality, Asian Biomedicine is poised to play an increasingly important role in the advancement of biomedical research in Asia and beyond.

CURRENT MICROBIOLOGY, published by SPRINGER, is a renowned journal that serves as a critical platform for the dissemination of cutting-edge research in the field of microbiology. With an ISSN of 0343-8651 and an E-ISSN of 1432-0991, this journal contributes significantly to the scientific community by covering a diverse range of topics from applied microbiology and biotechnology to various aspects of medicine. Currently operating an impact factor that places it within the Q2 quartile in both applied microbiology and biotechnology and medicine (miscellaneous), along with a Q3 ranking in microbiology, CURRENT MICROBIOLOGY is recognized for its valuable contributions to these dynamic fields. This journal, which has documented the evolution of microbiological research since its inception in 1978, provides an essential venue for researchers, professionals, and students alike to explore innovative studies and advances. Although it does not offer open access, the journal remains a pivotal resource within its category, complementing the ongoing growth and exploration of microbiology from its headquarters at One New York Plaza, Suite 4600, New York, NY 10004, United States. Its Scopus rankings highlight its reputable standing, making it a key publication for anyone aiming to stay at the forefront of microbiological science.

Biochemia Medica is a premier open-access journal that has been at the forefront of advancing knowledge in the fields of medical biochemistry and laboratory medicine since its inception in 2006. Published by the Croatian Society of Medical Biochemistry & Laboratory Medicine, this journal serves a vital role in disseminating high-quality research findings and reviews that contribute to the understanding of biochemical processes in health and disease. With an impressive performance in the Scopus ranking, it holds a Q2 quartile category in both medical biochemistry and clinical biochemistry for 2023, reflecting its commitment to scholarly excellence and relevance in the field. As an open-access journal, Biochemia Medica ensures that research is freely accessible, fostering collaboration and innovation among researchers, healthcare professionals, and students globally. Positioned within a rapidly evolving scientific landscape, this journal is dedicated to bridging the gap between laboratory research and clinical application, making it an indispensable resource for anyone interested in the intersections of biochemistry and medicine.